Kyle Moran is CFO at Wave Life Sciences Ltd. (WVE). They have made 3 open-market trades across 1 company since 2021, most recently 2026-02-09.
CIK 0001657765
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WVE | 134,385 | $421K |
Shares reported on the most recent Form 4, priced at the 2026-02-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WVE | SELL | 2026-02-09 | 2026-02-11 | $13.45 | $48K | +6.3% | -1.3% | -48.6% |
| WVE | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $15.78 | $4.1M | -9.3% | -30.2% | -30.6% |
| WVE | SELL · 10b5-1 | 2024-09-25 | 2024-09-27 | $9.00 | $154K | +1.0% | +80.0% | +61.8% |
| WVE | SELL · 10b5-1 | 2024-04-03 | 2024-04-05 | $6.17 | $193K | -19.0% | -2.7% | -7.4% |
| WVE | SELL · 10b5-1 | 2023-08-23 | 2023-08-23 | $4.75 | $352K | -9.2% | +11.0% | +7.1% |
| WVE | SELL | 2023-02-16 | 2023-02-17 | $4.04 | $39K | -13.5% | -11.8% | -24.9% |
| WVE | SELL · 10b5-1 | 2022-05-05 | 2022-05-06 | $1.72 | $9K | -25.9% | +10.6% | +41.8% |
| WVE | SELL | 2022-02-16 | 2022-02-18 | $2.31 | $21K | -18.4% | -17.4% | -56.7% |
| WVE | SELL · 10b5-1 | 2021-02-16 | 2021-02-18 | $10.57 | $18K | +6.3% | +4.6% | -33.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.